Pancreatic Neoplasms: all 3,310 studies
Page 6 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D MutationRecruitingNCT06385925Phase 1/2
- The Role of the Human Microbiome in Patients After Pancreatic Resection.Enrolling by invitationNCT06381882
- A Phase I/II Trial of UCB4594 in Participants With Advanced CancerRecruitingNCT06380816Phase 1/2
- EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)Not yet recruitingNCT06375954Not applicable
- Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer PatientsRecruitingNCT06375473
- Newly Emerging Immunotherapy for Pancreatic Cancer TreatmentNot yet recruitingNCT06370754Phase 1/2
- The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic CancerRecruitingNCT06368063Phase 4
- A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic CancerRecruitingNCT06361888Phase 2/3
- Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic CancerRecruitingNCT06361316Not applicable
- Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic CancerNot yet recruitingNCT06361030Phase 2
- PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence PatientsRecruitingNCT06359275Phase 2
- XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic CancerRecruitingNCT06353646Not applicable
- Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOXRecruitingNCT06349278Not applicable
- Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPCNot yet recruitingNCT06346808Phase 1
- NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory StudyRecruitingNCT06345300Phase 2
- Iconographic Registry of Pancreatobiliary Endoscopy ProceduresRecruitingNCT06344507
- Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy As an Adjuvant Therapy for Pancreatic CancerRecruitingNCT06344156Phase 1
- The Optimal Number of Fiducial Marker for Stereotactic Body RadiotherapyRecruitingNCT06342323
- EUS Examination Using EndoSound Vision System vs. Standard EchoendoscopeRecruitingNCT06340620Not applicable
- tislelizUMaB in canceR Patients With molEcuLar residuaL DiseaseRecruitingNCT06332274Phase 3
- Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic CancerRecruitingNCT06326736Early Phase 1
- Characteristics of Intestinal Microbiome Following Pancreatic SurgeryRecruitingNCT06319755
- Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching AnalysisRecruitingNCT06316466
- Exercise to Boost Immunity in Advanced CancerNot yet recruitingNCT06310993Not applicable
- Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer PatientsRecruitingNCT06310902
- Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver MetastasisRecruitingNCT06307080Not applicable
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerRecruitingNCT06298916Phase 1/2
- Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in UrineRecruitingNCT06291779
- The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor SurgeryRecruitingNCT06289803Not applicable
- Pancreatic Cancer Initial Detection Via Liquid BiopsyEnrolling by invitationNCT06283576
- The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using HistotripsyRecruitingNCT06282809Not applicable
- Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)RecruitingNCT06277531
- The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)Enrolling by invitationNCT06276764
- Pancreatic Cancer Detection Consortium (PCDC) Prospective CohortsRecruitingNCT06271291
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.RecruitingNCT06263088Not applicable
- Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic CancerNot yet recruitingNCT06259058Phase 1/2
- Clinical Trial for Advanced or Metastatic Pancreatic CancerNot yet recruitingNCT06255912Phase 2
- Promoting CT Engagement for Pancreatic Cancer With AppRecruitingNCT06252545Not applicable
- mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to ChemotherapyRecruitingNCT06249321Phase 2
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer PatientsNot yet recruitingNCT06234072Phase 2
- Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic CancerNot yet recruitingNCT06233877Phase 2
- A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic CancerNot yet recruitingNCT06233864Phase 2
- Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic CancerNot yet recruitingNCT06231160
- Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS MutationsRecruitingNCT06229340Phase 2
- Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer RecurrenceRecruitingNCT06228599Not applicable
- Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)Not yet recruitingNCT06217666Phase 1
- HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic CancerNot yet recruitingNCT06217042Phase 3
- PRIORITY-CONNECT 2 Pilot TrialRecruitingNCT06212700Not applicable
- Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOXNot yet recruitingNCT06210360Phase 2
- The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic CancerRecruitingNCT06208436
- Surgical Results of Resection of Locally Advanced Pancreatic CancerNot yet recruitingNCT06206382
- Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas CancerRecruitingNCT06205849Phase 1
- Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic CancerNot yet recruitingNCT06203821Phase 1
- Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic CancerRecruitingNCT06203613Not applicable
- Use of Ctdna in Patients With Gastrointestinal Tract TumorsRecruitingNCT06202131
- Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPCRecruitingNCT06202014Phase 2
- Transcatheter Arterial Infusion to Patients With Advanced Pancreatic CancerRecruitingNCT06196788Phase 2
- Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic CancerNot yet recruitingNCT06196671Phase 2
- GPC3/Mesothelin-CAR-γδT Cells Against CancersRecruitingNCT06196294Phase 1
- Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic CancerNot yet recruitingNCT06177522Phase 2
- A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First-line or More Standard ChemotherapyNot yet recruitingNCT06172634Phase 1/2
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Irinotecan Liposome for Resectable Pancreatic Cancer With or Without AddebelizumabNot yet recruitingNCT06172036Phase 2
- Fluorescent Navigation Technology in Radical Resection of Pancreatic CancerNot yet recruitingNCT06168552Phase 1/2
- Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal PancreatectomyNot yet recruitingNCT06167421Not applicable
- Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic CancerNot yet recruitingNCT06166589Phase 2
- A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early DetectionRecruitingNCT06166147
- Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric ArteryRecruitingNCT06164769Not applicable
- Feasibility Trial of EUS-PCA in IPMN Pancreatic CystsNot yet recruitingNCT06162468Not applicable
- Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic CancerRecruitingNCT06160323Not applicable
- Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)RecruitingNCT06159478Phase 2
- Autologous CAR-T Cells Targeting B7-H3 in PDACRecruitingNCT06158139Phase 1
- 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine TumoursRecruitingNCT06155318
- Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPCNot yet recruitingNCT06153368Phase 2
- A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic CancerRecruitingNCT06151262Phase 2
- A Prospective Registry for Patients at High-Risk for Pancreatic CancerRecruitingNCT06151223
- Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)RecruitingNCT06149546Not applicable
- Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing CancerRecruitingNCT06148298
- Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.RecruitingNCT06145074Phase 2
- Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic CancerRecruitingNCT06144762Not applicable
- Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT06141031Phase 1
- Early-stage Detection of LIver, Biliary TRAct and PancReatic CancersRecruitingNCT06139042
- Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary CancersRecruitingNCT06135896Phase 2
- Dissecting the Pattern of Nodal Spread in Post-neoadjuvant PancreatoduodenectomyRecruitingNCT06135649
- NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid TumorRecruitingNCT06134960Phase 1
- Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic CancerNot yet recruitingNCT06134765Phase 2
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
- Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid TumorsRecruitingNCT06126406Phase 1
- Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk IndividualsRecruitingNCT06122896Early Phase 1
- A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic CancerRecruitingNCT06111274Phase 2
- Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer PatientRecruitingNCT06090825
- Use Of Indocyanine Green In Pancreas SurgeryRecruitingNCT06084013
- AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic CancerNot yet recruitingNCT06080854Phase 2
- Olaparib in PALB2 Advanced Pancreatic CancerRecruitingNCT06078787Phase 2
- Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary CarcinomaEnrolling by invitationNCT06076252Not applicable
- LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer CachexiaRecruitingNCT06073431
- Management of Malignant Gastric Outlet Obstruction Between Surgery and EndoscopyRecruitingNCT06071507
- Prehabilitation in Pancreatic SurgeryRecruitingNCT06069297Not applicable